This is a news story, published by PBS, that relates primarily to William Brangham news.
For more William Brangham news, you can click here:
more William Brangham newsFor more weightlifting & bodybuilding news, you can click here:
more weightlifting & bodybuilding newsFor more news from PBS, you can click here:
more news from PBSOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like weightlifting & bodybuilding news, you might also like this article about
PBS News Hour. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest journalism news, newsletter news, weightlifting & bodybuilding news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
weight loss drugsPBS
•Health
Health
59% Informative
The future of public media depends on viewers like you.
William Brangham reports on the rising demand for weight loss drugs like Ozempic and Wegovy .
Don’t wait, our match expires at midnight on December 31 —this is your last chance to keep PBS News Hour strong.
VR Score
59
Informative language
58
Neutral language
4
Article tone
semi-formal
Language
English
Language complexity
35
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
